SG Americas Securities LLC Acquires Shares of 60,497 Cronos Group Inc (CRON)

SG Americas Securities LLC acquired a new position in shares of Cronos Group Inc (NASDAQ:CRON) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 60,497 shares of the company’s stock, valued at approximately $1,115,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. RPG Investment Advisory LLC boosted its position in Cronos Group by 237.5% during the 1st quarter. RPG Investment Advisory LLC now owns 1,350 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares during the period. Kistler Tiffany Companies LLC lifted its holdings in shares of Cronos Group by 125.0% during the 1st quarter. Kistler Tiffany Companies LLC now owns 1,755 shares of the company’s stock valued at $32,000 after buying an additional 975 shares during the last quarter. Whitnell & Co. acquired a new stake in shares of Cronos Group during the 1st quarter valued at about $35,000. James Investment Research Inc. acquired a new stake in shares of Cronos Group during the 1st quarter valued at about $40,000. Finally, Hudock Capital Group LLC lifted its holdings in shares of Cronos Group by 8,816.0% during the 1st quarter. Hudock Capital Group LLC now owns 2,229 shares of the company’s stock valued at $41,000 after buying an additional 2,204 shares during the last quarter. Hedge funds and other institutional investors own 5.58% of the company’s stock.

Shares of Cronos Group stock opened at $15.24 on Wednesday. The stock has a market cap of $4.74 billion, a PE ratio of 50.89 and a beta of 3.84. Cronos Group Inc has a 52-week low of $5.61 and a 52-week high of $25.10.



Cronos Group (NASDAQ:CRON) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.38. The business had revenue of $6.47 million during the quarter, compared to analyst estimates of $6.87 million. Cronos Group had a return on equity of 99.44% and a net margin of 2,107.83%. Cronos Group’s quarterly revenue was up 119.3% on a year-over-year basis. Sell-side analysts anticipate that Cronos Group Inc will post -0.04 earnings per share for the current year.

Several equities research analysts have recently issued reports on CRON shares. Bank of America started coverage on Cronos Group in a report on Wednesday, April 17th. They set an “underperform” rating and a $13.00 price target for the company. Zacks Investment Research upgraded Cronos Group from a “strong sell” rating to a “hold” rating in a report on Friday, May 10th. GMP Securities lowered Cronos Group from a “buy” rating to a “hold” rating in a report on Tuesday, February 5th. They noted that the move was a valuation call. Canaccord Genuity lowered Cronos Group from a “hold” rating to a “sell” rating and set a $17.00 price target for the company. in a report on Wednesday, March 27th. Finally, Jefferies Financial Group started coverage on Cronos Group in a report on Monday, February 25th. They set an “underperform” rating for the company. Five analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $17.03.

TRADEMARK VIOLATION WARNING: “SG Americas Securities LLC Acquires Shares of 60,497 Cronos Group Inc (CRON)” was first published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://dakotafinancialnews.com/2019/05/15/sg-americas-securities-llc-acquires-shares-of-60497-cronos-group-inc-cron.html.

Cronos Group Profile

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

Recommended Story: Put Option

Want to see what other hedge funds are holding CRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cronos Group Inc (NASDAQ:CRON).

Institutional Ownership by Quarter for Cronos Group (NASDAQ:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.